查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1400996

鴉片類藥物使用障礙 (OUD) 市場，按藥物類型、給藥途徑、配銷通路、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Opioid Use Disorder (OUD) Market, by Drug Type, by Route of Administration, by Distribution channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 277 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年鴉片類藥物使用障礙 (OUD) 市場規模為 28.001 億美元，2023 年至 2030 年CAGR為 10.59%。

鴉片類藥物使用疾患 (OUD) 市場-市場動態

鴉片類藥物成癮病例增加推動市場需求

目前，全世界人口都受到各種嚴重和慢性疾病的困擾，包括心血管疾病、癌症和其他疾病。為了治療這些問題，使用止痛藥，特別是鴉片類藥物。吸毒常導致病人吸毒成癮。患者可能由於對這些治療的依賴增加和突然停藥而出現戒斷症狀。據 CDC 稱，預計 2021 年美國 12 歲及以上的人口將有 270 萬人患有 OUD。

鴉片類藥物使用障礙 (OUD) 市場 - 關鍵見解

根據我們的研究分析師分享的分析，全球鴉片類藥物使用障礙 (OUD) 市場預計在預測期內（2023-2030 年）每年將以 10.59% 左右的CAGR成長

由於鴉片類藥物成癮病例的增加，鴉片類藥物使用障礙（OUD）行業預計將以顯著的速度成長

根據藥物類型細分，預計激動劑將在 2022 年顯示最大的市場佔有率

依給藥途徑細分，2022年靜脈注射為主導類型

從配銷通路細分來看，2022年醫院藥局是主導類型

按地區分類，北美是 2022 年的主要收入來源

鴉片類藥物使用疾患 (OUD) 市場區隔分析：

全球鴉片類藥物使用障礙 (OUD) 市場根據藥物類型、給藥途徑、配銷通路和區域進行細分。

根據藥物類型，市場分為三類：激動劑和拮抗劑。由於慢性疼痛發病率的上升、鴉片類藥物的大量濫用以及易患疼痛疾病的老年人口不斷增加，預計激動劑領域將主導市場。

根據配銷通路，市場分為兩類：醫院藥房和零售藥房。由於患者群體依賴該管道來輸送丁丙諾啡等腸外 OUD 藥物，醫院藥房預計將佔據全球市場的較大佔有率。

鴉片類藥物使用障礙 (OUD) 市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。北美很可能引領市場。這是由於美國有大量的人患有鴉片類藥物成癮，該地區存在重要的利益相關者，以及地方政府擴大參與對抗這場流行病。根據美國國家生物技術資訊中心 (NCBI) 2020 年發布的一篇文章，美國約有 210 萬人患有鴉片類藥物使用障礙。

鴉片類藥物使用疾患 (OUD) 市場-競爭格局：

由於未來幾年空調需求的持續發展，全球空氣對空氣熱泵市場由國際和本地生產商組成，使其成為世界上最具競爭力的行業之一。公司透過多種管道銷售產品，包括企業網站、電子商務網站、零售商、分銷​​商和最終消費者。產品製造商在多個方面競爭，包括產品成本、性能、產品製造、配銷通路、聲譽和可用性。企業用來擴大影響力和擴大市場佔有率的一些主要技術包括新產品發布、分銷網路開發、研發支出以及併購。例如，2023 年 4 月，紐約州成癮服務和支持辦公室 (OASAS) 和紐約州衛生部 (DOH) 宣布推出丁丙諾啡援助試點計劃，該計劃將幫助支付鴉片類藥物的丁丙諾啡費用使用障礙（OUD）治療。

最近的發展：

2023年3月，Indivior PLC完成對Opiant Pharmaceuticals, Inc.的收購。此次收購將提高 Indivior 在成癮治療領域的地位。

目錄

第 1 章：鴉片類藥物使用障礙 (OUD) 市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按藥物類型分類的鴉片類藥物使用障礙 (OUD) 市場片段
    • 按給藥途徑分類的鴉片類藥物使用障礙 (OUD) 市場片段
    • 按配銷通路的鴉片類藥物使用障礙 (OUD) 市場片段
    • 鴉片類藥物使用障礙 (OUD) 市場片段（按國家/地區）
    • 鴉片類藥物使用疾患 (OUD) 市場片段（按地區）
  • 競爭洞察

第 3 章：鴉片類藥物使用障礙 (OUD) 主要市場趨勢

  • 鴉片類藥物使用疾患 (OUD) 市場促進因素
    • 市場促進因素的影響分析
  • 鴉片類藥物使用疾患 (OUD) 市場限制
    • 市場限制影響分析
  • 鴉片類藥物使用疾患 (OUD) 市場機會
  • 鴉片類藥物使用疾患 (OUD) 市場未來趨勢

第 4 章：鴉片類藥物使用障礙 (OUD) 產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：鴉片類藥物使用障礙 (OUD) 市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：鴉片類藥物使用障礙 (OUD) 市場格局

  • 2022 年鴉片類藥物使用障礙 (OUD) 市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：鴉片類藥物使用障礙 (OUD) 市場 - 按藥物類型

  • 概述
    • 按藥物類型分類的細分市場佔有率分析
    • 激動劑
    • 拮抗劑

第 8 章：鴉片類藥物使用障礙 (OUD) 市場 - 按給藥途徑

  • 概述
    • 按給藥途徑分類的細分市佔率分析
    • 口服
    • 靜脈
    • 舌下含化

第 9 章：鴉片類藥物使用障礙 (OUD) 市場 - 按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 醫院藥房
    • 零售藥房

第 10 章：鴉片類藥物使用障礙 (OUD) 市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美鴉片類藥物使用障礙 (OUD) 主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按藥物類型）
    • 北美市場規模與預測（按管理途徑）
    • 北美市場規模和預測（按配銷通路）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲鴉片類藥物使用障礙 (OUD) 主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按藥物類型）
    • 歐洲市場規模與預測（按管理途徑）
    • 歐洲市場規模和預測（按配銷通路）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區鴉片類藥物使用障礙 (OUD) 主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模和預測（按藥物類型）
    • 亞太地區市場規模與預測（依管理途徑）
    • 亞太地區市場規模和預測（按配銷通路）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲鴉片類藥物使用障礙 (OUD) 主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按藥物類型）
    • 拉丁美洲市場規模與預測（按管理途徑）
    • 拉丁美洲市場規模和預測（按配銷通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲鴉片類藥物使用疾患 (OUD) 主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按藥物類型）
    • 中東和非洲市場規模及預測（按管理途徑）
    • 中東和非洲市場規模及預測（按配銷通路）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 鴉片類藥物使用障礙 (OUD) 產業

  • 競爭儀表板
  • 公司簡介
    • Indivior PLC
    • Alkermes plc
    • Mallinckrodt Pharmaceuticals
    • Reckitt Benckiser Pharmaceuticals (RB)
    • Teva Pharmaceutical Industries Ltd.
    • Mylan NV (now part of Viatris Inc.)
    • Otsuka America Pharmaceutical, Inc.
    • Hikma Pharmaceuticals PLC
    • Braeburn Pharmaceuticals
    • Titan Pharmaceuticals, Inc.
    • Camurus AB
    • BioDelivery Sciences International, Inc.
    • Titan Pharmaceuticals, Inc.
    • Esperion Therapeutics, Inc.
    • Kaleo Pharmaceuticals (Known for naloxone products)

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1960

REPORT HIGHLIGHT

Opioid Use Disorder (OUD) Market size was valued at USD 2,800.1 Million in 2022, expanding at a CAGR of 10.59% from 2023 to 2030.

Opioid Use Disorder (OUD) is a chronic health disorder defined by the obsessive and dangerous use of opioids, which can include prescribed medications as well as illegal narcotics such as heroin. It is characterized by a variety of symptoms, including cravings, withdrawal, tolerance, and poor social and vocational performance. Medication-assisted therapy and psychological support are frequently used in effective treatment to help patients recover control of their lives and minimize opiate dependence.

Opioid Use Disorder (OUD) Market- Market Dynamics

Increasing Opioid Addiction Cases to propel market demand

The worldwide population is currently afflicted with a wide spectrum of severe and chronic diseases, including cardiovascular ailments, cancer, and other conditions. To treat these problems, painkillers, particularly opioids, are used. Drug usage frequently leads to drug addiction in patients. Patients may develop drug withdrawal symptoms as a result of their increasing reliance on these treatments and their sudden discontinuation. According to the CDC, a projected 2.7 million persons aged 12 and over in the United States will have OUD in 2021.

Opioid Use Disorder (OUD) Market- Key Insights

As per the analysis shared by our research analyst, the global Opioid Use Disorder (OUD) market is estimated to grow annually at a CAGR of around 10.59% over the forecast period (2023-2030)

The Opioid Use Disorder (OUD) industry is projected to grow at a significant rate due to the increasing opioid addiction cases

Based on drug type segmentation, agonist was predicted to show maximum market share in the year 2022

Based on route of administration segmentation, Intravenous was the leading type in 2022

Based on distribution channel segmentation, hospital pharmacy was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Opioid Use Disorder (OUD) Market- Segmentation Analysis:

The Global Opioid Use Disorder (OUD) Market is segmented on the basis of Drug Type, Route of Administration, Distribution channel, and Region.

The market is divided into three categories based on Drug Type: agonist and antagonist. Due to the rise in the incidence of chronic pain, a significant amount of opioid misuse, and the expanding elderly population susceptible to painful diseases, the agonist segment is predicted to dominate the market.

The market is divided into two categories based on distribution channel: hospital pharmacy and retail pharmacy. The hospital pharmacies segment is expected to account for a larger part of the worldwide market due to the patient population's reliance on this channel for the delivery of parenteral OUD medications such as buprenorphine.

Opioid Use Disorder (OUD) Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is likely to lead the market. This is due to the large number of people in the United States suffering from opioid addiction, the presence of significant stakeholders in the region, and the rising participation of local governments in combating the pandemic. According to a 2020 article released by the National Center for Biotechnology Information (NCBI), around 2.1 million people in the United States suffer with Opioid Use Disorder.

Opioid Use Disorder (OUD) Market- Competitive Landscape:

Due to the continued development in demand for air conditioning in the coming years, the worldwide market for air-to-air heat pumps is made of both international and local producers, making it one of the most competitive sectors in the world. Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, Distribution channel, reputation, and availability. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, April 2023, the New York State Office of Addiction Services and Supports (OASAS) and the New York State Department of Health (DOH) announced the introduction of the Buprenorphine Assistance Pilot Program, which will help with the expense of buprenorphine for opioid use disorder (OUD) treatment.

Recent Developments:

In March 2023, the acquisition of Opiant Pharmaceuticals, Inc. by Indivior PLC was finalized. The purchase will improve Indivior's position in the field of addiction therapy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL OPIOID USE DISORDER (OUD) MARKET KEY PLAYERS

  • Indivior PLC
  • Alkermes plc
  • Mallinckrodt Pharmaceuticals
  • Reckitt Benckiser Pharmaceuticals (RB)
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V. (now part of Viatris Inc.)
  • Otsuka America Pharmaceutical, Inc.
  • Hikma Pharmaceuticals PLC
  • Braeburn Pharmaceuticals
  • Titan Pharmaceuticals, Inc.
  • Camurus AB
  • BioDelivery Sciences International, Inc.
  • Titan Pharmaceuticals, Inc.
  • Esperion Therapeutics, Inc.
  • Kaleo Pharmaceuticals (Known for naloxone products)

GLOBAL OPIOID USE DISORDER (OUD) MARKET, BY DRUG TYPE

  • Agonist
  • Antagonist

GLOBAL OPIOID USE DISORDER (OUD) MARKET, BY ROUTE OF ADMINISTRATION

  • Oral
  • Intravenous
  • Sublingual

GLOBAL OPIOID USE DISORDER (OUD) MARKET, BY DISTRIBUTION CHANNEL

  • Hospital Pharmacy
  • Retail Pharmacy

GLOBAL OPIOID USE DISORDER (OUD) MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Opioid Use Disorder (OUD) Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Opioid Use Disorder (OUD) Market Snippet by Drug Type
    • 2.1.2. Opioid Use Disorder (OUD) Market Snippet by Route of Administration
    • 2.1.3. Opioid Use Disorder (OUD) Market Snippet by Distribution Channel
    • 2.1.4. Opioid Use Disorder (OUD) Market Snippet by Country
    • 2.1.5. Opioid Use Disorder (OUD) Market Snippet by Region
  • 2.2. Competitive Insights

3. Opioid Use Disorder (OUD) Key Market Trends

  • 3.1. Opioid Use Disorder (OUD) Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Opioid Use Disorder (OUD) Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Opioid Use Disorder (OUD) Market Opportunities
  • 3.4. Opioid Use Disorder (OUD) Market Future Trends

4. Opioid Use Disorder (OUD) Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Opioid Use Disorder (OUD) Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Opioid Use Disorder (OUD) Market Landscape

  • 6.1. Opioid Use Disorder (OUD) Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Opioid Use Disorder (OUD) Market - By Drug Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Type, 2022 & 2030 (%)
    • 7.1.2. Agonist
    • 7.1.3. Antagonist

8. Opioid Use Disorder (OUD) Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Oral
    • 8.1.3. Intravenous
    • 8.1.4. Sublingual

9. Opioid Use Disorder (OUD) Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
    • 9.1.2. Hospital Pharmacy
    • 9.1.3. Retail Pharmacy

10. Opioid Use Disorder (OUD) Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Opioid Use Disorder (OUD) Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Opioid Use Disorder (OUD) Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Opioid Use Disorder (OUD) Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Opioid Use Disorder (OUD) Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Opioid Use Disorder (OUD) Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Opioid Use Disorder (OUD) Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Indivior PLC
    • 11.2.2. Alkermes plc
    • 11.2.3. Mallinckrodt Pharmaceuticals
    • 11.2.4. Reckitt Benckiser Pharmaceuticals (RB)
    • 11.2.5. Teva Pharmaceutical Industries Ltd.
    • 11.2.6. Mylan N.V. (now part of Viatris Inc.)
    • 11.2.7. Otsuka America Pharmaceutical, Inc.
    • 11.2.8. Hikma Pharmaceuticals PLC
    • 11.2.9. Braeburn Pharmaceuticals
    • 11.2.10. Titan Pharmaceuticals, Inc.
    • 11.2.11. Camurus AB
    • 11.2.12. BioDelivery Sciences International, Inc.
    • 11.2.13. Titan Pharmaceuticals, Inc.
    • 11.2.14. Esperion Therapeutics, Inc.
    • 11.2.15. Kaleo Pharmaceuticals (Known for naloxone products)

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Opioid Use Disorder (OUD) Market: Drug Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Type
  • TABLE Global Opioid Use Disorder (OUD) Market, by Drug Type 2018-2030 (USD Million)
  • TABLE Opioid Use Disorder (OUD) Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Opioid Use Disorder (OUD) Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Opioid Use Disorder (OUD) Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Opioid Use Disorder (OUD) Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE Opioid Use Disorder (OUD) Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Opioid Use Disorder (OUD) Market, by Region 2018-2030 (USD Million)
  • TABLE North America Opioid Use Disorder (OUD) Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Opioid Use Disorder (OUD) Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE North America Opioid Use Disorder (OUD) Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Opioid Use Disorder (OUD) Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe Opioid Use Disorder (OUD) Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Opioid Use Disorder (OUD) Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Europe Opioid Use Disorder (OUD) Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Opioid Use Disorder (OUD) Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Opioid Use Disorder (OUD) Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Opioid Use Disorder (OUD) Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Opioid Use Disorder (OUD) Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Opioid Use Disorder (OUD) Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America Opioid Use Disorder (OUD) Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Opioid Use Disorder (OUD) Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Latin America Opioid Use Disorder (OUD) Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Opioid Use Disorder (OUD) Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Opioid Use Disorder (OUD) Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Opioid Use Disorder (OUD) Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Opioid Use Disorder (OUD) Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Opioid Use Disorder (OUD) Market, by Distribution Channel, 2018-2030 (USD Million)